30 July 2020
Visiongain has launched a new report Pregnancy Care Products Market Report 2020-2030: Forecasts by Product (Toning/Firming Lotion, Body Restructuring Gel, Breast Cream, Stretch Mark Minimizer, Other Products), Distribution Channels (Hospital Pharmacies, Retail pharmacies, Online Stores, Others), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.
Pregnancy care products help to keep the mother and baby safe and healthy. Proper care such as healthy habits and good nutritious diet is required before and after pregnancy. These products help women to deal with physical changes such as stretch marks and hormonal changes that affect skin and hair. There is increase in the use of products such as stretchmark minimizers and breast cream that help to retain skin hydration, improve elasticity, and strengthen breasts.
The shift in trend of using commercially available products as opposed to traditional home remedies has increased the focus of consumers to the use of safer and effective pregnancy care products. The large number of pregnancy globally, the increase in awareness regarding the benefits of using these products, and rise in disposable income in developing countries are some of the factors that contribute towards the growth of pregnancy care products market. For instance, according to the WHO report, almost 61 births per 1,000 women between the age of 15 and 44 were observed in the year range 2016-2017. Such factors help to boost the market growth.
The increase in the R&D activities for the development of more safer and effective products have led to the emergence of organic alternatives. As these products are more safe, there is increase in preference for organic pregnancy care products as compared to chemical-based ones. Increased focus of women on physical appearance after pregnancy and extensive campaigns conducted by market players through social media are influencing and increasing the adoption of pregnancy care products.
The advancement in development of better products, increase in purchasing power of women, and increase in awareness the benefits of using organic variants of the product further drives the growth of global pregnancy care products market. However, the high cost of these products and side effects of some products are expected to hamper the market growth.
The Visiongain report analyst commented “Advancement in development of organic pregnancy care products that are more safe and effective to improve physical appearance concerns such as stretchmark and sagging breasts and increase in awareness of the benefits of using these products through promotion of these products on social media platforms have increased the demand for pregnancy care products.”
The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Abbott, Clarins Group, E.T. Browne Drug, Expanscience Laboratories, Mankind Pharma, Nine Naturals, Mama Mio, Noodle and Boo, Novena Maternal Skin Care, and Procter & Gamble.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.
25 November 2022
Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.
25 November 2022
The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.
23 November 2022
The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.